Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Conditions
- Mucinous Adenocarcinoma of the Colon
- Mucinous Adenocarcinoma of the Rectum
- Recurrent Colon Cancer
- Recurrent Rectal Cancer
- Signet Ring Adenocarcinoma of the Colon
- Signet Ring Adenocarcinoma of the Rectum
- Stage IV Colon Cancer
- Stage IV Rectal Cancer
Interventions
- BIOLOGICAL: panitumumab
- DRUG: irinotecan hydrochloride
- DRUG: fluorouracil
- DRUG: leucovorin calcium
Sponsor
John Hays
Collaborators